37.5 "

: Sutent 37.5 Mg. ?  »
|
-

PER OS

Capsules

Sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. Sutent is indicated for the treatment of advanced renal cell carcinoma.Treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pNET) with disease progression.

142 82 32953 00

Pfizer Italia S.r.l., Italy

.
, .
.
/
Sunitinib as malate 37.5 MG
Blister pvc/aluminium 7 x CAPSULES 36
Blister pvc/aluminium 28 x CAPSULES 36
Bottle hdpe 30 x CAPSULES 36

*

*

 

.

?

!
!
 »
 
" !
 

- !
:  »
238
, ,